Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JACC. Cardiovascular Interventions|May 26, 2009
Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent StudyJohn A Ormiston, Ehtisham Mahmud, Mark A Turco, et al.
JACC. Cardiovascular Interventions|May 26, 2009
TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS programEhtisham Mahmud, John A Ormiston, Mark A Turco, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 7, 2010
Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting stentsNeil J Weissman, Mark A Turco, John A Ormiston, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trialEugenia Nikolsky, Gregg W Stone, Edwin Lee, et al.
Circulation. Cardiovascular Interventions|April 13, 2012
Impact of drug-eluting stents on distal vesselsKohei Wakabayashi, Gary S Mintz, Neil J Weissman, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 7, 2011
Long-term benefit of the TAXUS Liberté stent in small vessels and long lesions. TAXUS ATLAS programJohn A Ormiston, Mark A Turco, Jack J Hall, et al.
Journal of the American College of Cardiology|June 3, 2004
Primary angioplasty in acute myocardial infarction at hospitals with no surgery on-site (the PAMI-No SOS study) versus transfer to surgical centers for primary angioplastyThomas P Wharton, Lorelei L Grines, Mark A Turco, et al.
Journal of the American College of Cardiology|April 24, 2007
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trialMark A Turco, John A Ormiston, Jeffrey J Popma, et al.
Pageof 4